Oct. 2019, FAM19A4/miR124-2 methylation shows higher sensitivity than cytology for detection of CIN3+ in women living with HIV

October 2019, HPV-Risk assay clinically validated on SurePath cervical screening samples

December 2018, Self-screen and Novosanis received a prestigious Eurostar grant

February 2019, Results from an international study confirm the robustness of the QIAsure Methylation Test

November 2018, QIAGEN launches Self-screens HPV-Risk Assay as the QIAscreen HPV PCR Test

September 2018, Self-screen successfully passed the transition to the ISO13485:2016 standard